Susquehanna International Group, LLP Fennec Pharmaceuticals Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 30,258 shares of FENC stock, worth $254,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,258

Previous 12,432 143.39%

Holding current value

$254,469

Previous $78,000 135.9%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$5.54 - $7.02 $98,756 - $125,138	17,826 Added 143.39%	30,258 $184,000
Q4 2024 Feb 14, 2025	BUY	$3.99 - $6.37 $49,603 - $79,191	12,432 New	12,432 $78,000
Q1 2024 May 07, 2024	BUY	$8.82 - $11.12 $66,670 - $84,056	7,559 Added 50.26%	22,599 $251,000
Q4 2023 Feb 14, 2024	BUY	$6.48 - $11.61 $97,459 - $174,614	15,040 New	15,040 $168,000
Q2 2023 Aug 11, 2023	SELL	$7.27 - $9.82 $1.09 Million - $1.47 Million	-149,891 Reduced 92.92%	11,429 $100,000
Q1 2023 May 16, 2023	BUY	$7.38 - $10.35 $396,357 - $555,867	53,707 Added 49.91%	161,320 $1.34 Million
Q4 2022 Feb 14, 2023	BUY	$7.63 - $10.22 $821,087 - $1.1 Million	107,613 New	107,613 $1.03 Million
Q2 2022 Aug 15, 2022	SELL	$5.17 - $6.33 $438,876 - $537,347	-84,889 Reduced 63.37%	49,075 $277,000
Q1 2022 May 16, 2022	SELL	$4.29 - $6.08 $587 - $832	-137 Reduced 0.1%	133,964 $750,000
Q4 2021 Feb 14, 2022	BUY	$3.89 - $10.01 $416,848 - $1.07 Million	107,159 Added 397.74%	134,101 $590,000
Q3 2021 Nov 15, 2021	BUY	$6.51 - $9.62 $81,661 - $120,673	12,544 Added 87.12%	26,942 $254,000
Q2 2021 Aug 11, 2021	BUY	$5.96 - $7.85 $85,812 - $113,024	14,398 New	14,398 $105,000
Q1 2021 May 17, 2021	SELL	$6.21 - $8.68 $70,595 - $98,674	-11,368 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.99 - $8.55 $128,737 - $183,756	-21,492 Reduced 65.4%	11,368 $85,000
Q3 2020 Nov 16, 2020	SELL	$5.19 - $10.17 $654,396 - $1.28 Million	-126,088 Reduced 79.33%	32,860 $199,000
Q2 2020 Aug 14, 2020	BUY	$5.43 - $9.39 $382,434 - $661,337	70,430 Added 79.57%	158,948 $1.33 Million
Q1 2020 May 15, 2020	BUY	$4.89 - $8.1 $155,218 - $257,110	31,742 Added 55.91%	88,518 $526,000
Q4 2019 Feb 14, 2020	BUY	$4.25 - $6.49 $147,628 - $225,436	34,736 Added 157.6%	56,776 $368,000
Q3 2019 Nov 14, 2019	BUY	$3.85 - $4.95 $84,854 - $109,098	22,040 New	22,040 $106,000
Q2 2018 Aug 14, 2018	SELL	$10.05 - $14.33 $569,905 - $812,611	-56,707 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.26 - $12.1 $468,399 - $686,154	56,707 New	56,707 $686,000

Others Institutions Holding FENC

# of Institutions

Shares Held

13.9M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $219M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Fennec Pharmaceuticals Inc. Transaction History